Help With Success In Health Wealth And Relationships
Pediatricians and parents are having difficulty accessing a new immunization used to prevent severe respiratory syncytial virus infections in infants. The drug, called nirsevimab and sold under the brand name Beyfortus, was approved by the Food and Drug Administration in July. The Centers for Disease Control and Prevention initially recommended that it be given to […]
Continue Reading | Priority Search Engine Submissions |
| 48 Hour Inclusion to all major search engines and web directories with PrioritySubmit.com! |
The Food and Drug Administration on Monday approved a shot to protect infants and vulnerable toddlers against respiratory syncytial virus, or R.S.V., offering one of the first protections for an illness that fills children’s hospitals year after year. The monoclonal antibody shot is expected to be available at the start of the fall R.S.V. season. […]
Continue Reading